Follicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin’s lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rate of more than 10 years. The other 20%, however, experience a quickly recurring or a more aggressive version. Now researchers from the University of Missouri School of Medicine may have found a way to identify the patients at risk of recurrence, without the need for imaging and surveillance testing. Their paper is published in the American Journal of Clinical Oncology.
This article was originally published on MedicalXpress.com
